Shanghai Fosun Pharmaceutical Group Co. Ltd.
Division of Fosun International Ltd.
www.fosunpharma.com/en
Latest From Shanghai Fosun Pharmaceutical Group Co. Ltd.
Sanofi Joins mRNA COVID-19 Club With Translate Tie-Up
The French drugmaker has joined the likes of Moderna, BioNTech and CureVac in advancing an mRNA vaccine against the virus that causes COVID-19 that could take the fraction of the time to develop compared with the old egg- and cell-based technology.
CureVac Denies Takeover Reports As It Slates Phase I Coronavirus Vaccine Study For Early Summer
The German biotech firm has denied receiving any offer from the Trump administration in a wide-ranging conference call that also addressed recent changes at the top, its clinical timeline for a coronavirus vaccine and new funds from the European Commission to boost production.
Some Caution Over 'People’s Hope' Remdesivir As China Trials Progress
Although Gilead’s remdesivir shows promise against the coronavirus, efficacy is not guaranteed, one antiviral company executive tells Scrip, as multiple other potential therapies and vaccines move forward.
Pfizer, Fosun Partner BioNTech On mRNA COVID-19 Vaccine
BioNTech extends Pfizer partnership to cover COVID-19 vaccine development and distribution while Fosun Pharma takes Chinese rights.
Company Information
- Industry
- Distributors
- In Vitro Diagnostics
- Medical Devices
-
Pharmaceuticals
- Vaccines
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gastrointestinal
- Infectious & Viral Diseases
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Asia
-
China
-
China
-
Asia
- Parent & Subsidiaries
-
Fosun International Ltd.
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Breas Medical AB
- Chongqing Fochon Pharmaceutical Research Co. Ltd.
- Hunan Dongting Pharmaceutical Co. Ltd.
- Jiangsu Wanbang Biochemical Pharmaceutical Group
- Jinzhou Ahon Pharmaceutical Co Ltd.
- Shanghai Chemo Wanbang Biopharma Co. Ltd.
- Shanghai Fosun Long March Medical Science Co. Ltd.
- Suzhou Erye Pharmaceutical Co. Ltd.
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Senior Management
-
Wu Yifang, Pres. & CEO
Guan Xiaohui, SVP, CFO
Shao Ying, VP, Dir, R&D - Contact Info
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
Phone: (86) 21 33987000
1289 Yishan Rd.
Bldg. A
Shanghai , 200233
China